Pressure Bio Closes $2M Private Placement, $500K Notes Offering | GenomeWeb

NEW YORK (GenomeWeb News) – Pressure BioSciences today announced the closing of the third and final tranche of its Series J Private Placement of Convertible Preferred Stock and Warrants that raised a total $2 million.

The first and second tranches closed in February and March. Investors in the Series J round included all members of Pressure Bio's board, as well as new and existing accredited investors in the company.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.